Cargando…

Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review

Metformin, an oral biguanide used for first-line treatment of type 2 diabetes mellitus, has attracted attention for its anti-proliferative and anti-cancer effects in several solid tumors, including prostate cancer (PCa). Liver kinase B1 (LKB1) and adenosine monophosphate-activated protein kinase (AM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Hyun Kyu, Lee, Young Hwa, Koo, Kyo Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698147/ https://www.ncbi.nlm.nih.gov/pubmed/33198356 http://dx.doi.org/10.3390/ijms21228540

Ejemplares similares

Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2021)

Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review
por: Kim, Tae Jin, et al.
Publicado: (2022)

Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review
por: Koo, Kyo Chul, et al.
Publicado: (2018)

Current Status and Future Perspectives of Immunotherapy for Locally Advanced or Metastatic Urothelial Carcinoma: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

Can microfocal prostate cancer be regarded as low-risk prostate cancer?
por: Lee, Seung Hwan, et al.
Publicado: (2013)

Comparison of the delta neutrophil index with procalcitonin, erythrocyte sedimentation rate, and C-reactive protein as predictors of sepsis in patients with acute prostatitis
por: Ahn, Hyun Kyu, et al.
Publicado: (2018)

Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008
por: Park, Jee Soo, et al.
Publicado: (2017)

Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)

Immunology and Immunotherapeutic Approaches for Advanced Renal Cell Carcinoma: A Comprehensive Review
por: Hah, Yoon-Soo, et al.
Publicado: (2021)

The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population
por: Park, Jee Soo, et al.
Publicado: (2019)

Role of the elastography strain ratio using transrectal ultrasonography in the diagnosis of prostate cancer and clinically significant prostate cancer
por: Yoo, Jeong Woo, et al.
Publicado: (2022)

Unrecognized Kinetics of Serum Testosterone: Impact on Short-Term Androgen Deprivation Therapy for Prostate Cancer
por: Koo, Kyo Chul, et al.
Publicado: (2014)

Metformin Pharmacogenomics: Current Status and Future Directions
por: Pawlyk, Aaron C., et al.
Publicado: (2014)

Clinical experience with active surveillance protocol using regular magnetic resonance imaging instead of regular repeat biopsy for monitoring: A study at a high-volume center in Korea
por: Ahn, Hyun Kyu, et al.
Publicado: (2021)

Metformin: current clinical applications in nondiabetic patients with cancer
por: Chen, Kailin, et al.
Publicado: (2020)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors
por: Koo, Kyo Chul, et al.
Publicado: (2013)

Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice
por: Oh, Kyung Tak, et al.
Publicado: (2020)

Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
por: Park, Jee Soo, et al.
Publicado: (2019)

Comprehensive Analysis of Individual Anatomical Structures for Micturition Symptoms and Maximum Flow Rate in Men With Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms
por: Kim, Dae Ho, et al.
Publicado: (2023)

Current status of active surveillance in prostate cancer
por: Chung, Mun Su, et al.
Publicado: (2016)

Leishmaniasis in Bolivia: Comprehensive Review and Current Status
por: Mollinedo, Sergio, et al.
Publicado: (2019)

Nonvisible tumors on multiparametric magnetic resonance imaging does not predict low-risk prostate cancer
por: Lee, Seung Hwan, et al.
Publicado: (2015)

Current Status of Brachytherapy for Prostate Cancer
por: Park, Dong Soo
Publicado: (2012)

Current Status of Biomarkers for Prostate Cancer
por: Velonas, Vicki M., et al.
Publicado: (2013)

Current status of theranostics in prostate cancer
por: Virgolini, Irene, et al.
Publicado: (2017)

Current Status of Radical Prostatectomy for High-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2014)

Korean Version of the Patient Perception of Study Medication Questionnaire: Translation and Linguistic Validation
por: Kim, Tae Jin, et al.
Publicado: (2022)

Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review
por: Malinowski, Bartosz, et al.
Publicado: (2019)

A comprehensive review of neuroanatomy of the prostate
por: Park, Yong Hyun, et al.
Publicado: (2013)

Current Status and Challenges of Cancer Clinical Trials in Korea
por: Shim, Byoung Yong, et al.
Publicado: (2016)

Comprehensive Review on Current Controversies and Debate in Prostate Artery Embolization
por: Maclean, Drew, et al.
Publicado: (2022)

Use of bisphosphonates in prostate cancer: Current status
por: Nayyar, Rishi, et al.
Publicado: (2007)

Focal therapy for prostate cancer: The current status
por: Marshall, Susan, et al.
Publicado: (2015)

Current Status of Cryotherapy for Prostate and Kidney Cancer
por: Cho, Seok, et al.
Publicado: (2014)

Clinical utility of current biomarkers for prostate cancer detection
por: Kim, Jeong Hyun, et al.
Publicado: (2021)

A Comprehensive Review of the Current Research Status of Biodegradable Zinc Alloys and Composites for Biomedical Applications
por: Kong, Lingyun, et al.
Publicado: (2023)

Machine Learning in Prostate MRI for Prostate Cancer: Current Status and Future Opportunities
por: Li, Huanye, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_huufp4ddo385t6muo15df356jb